Arizona State cornerback Keith Abney's NFL Draft prospects are being evaluated under the shadow of a detailed medical report. The analysis, released ahead of the 2026 selection process, provides teams with a full assessment of his injury history. This information is now a critical variable for franchises, including the Detroit Lions, as they formulate their draft boards.
The Lions, like all NFL teams, conduct rigorous due diligence on potential picks, with medical evaluations forming a cornerstone of the process. A significant injury history can dramatically alter a player's perceived value, causing them to slide down draft boards or be removed entirely. Teams must weigh raw talent against long-term durability and the risk of re-injury.
The specific contents of Abney's report were not detailed in the source, leaving the severity and nature of his injuries unclear. However, the mere existence of a prominent medical review suggests his physical condition is a point of scrutiny. How teams interpret this data will directly impact where, or if, he is selected in the 2026 draft.
For Detroit, this report injects uncertainty into their long-term planning. The franchise must decide if Abney's on-field talent outweighs the potential medical red flags. Their strategy in the cornerback market—whether to target him, look elsewhere, or use the information as leverage—will be shaped by this analysis.
Ultimately, the draft is an exercise in risk assessment. Abney's journey from college standout to professional will be a test case in how the league's decision-makers balance medical reports with game tape.